Wongsawat J. auteur aut IRD Puthanakit T. auteur aut IRD Kanjanavanit S. auteur aut IRD Hansudewechakul R. auteur aut IRD Ngampiyaskul C. auteur aut IRD Kerr S. J. auteur aut IRD Ubolyam S. auteur aut IRD Suwanlerk T. auteur aut IRD Kosalaraksa P. auteur aut IRD Luesomboon W. auteur aut IRD Ngo-Giang-Huong Nicole auteur aut IRD Chandara M. auteur aut IRD Saphonn V. auteur aut IRD Ruxrungtham K. auteur aut IRD Ananworanich J. auteur aut IRD text journalArticle eng text/pdf born digital access We evaluated the validity of CD4 count against CD4% criteria of 2008 World Health Organization guideline for initiating antiretroviral therapy using the data of 446 human immunodeficiency virus-infected Asian children aged 1 to 12 years who were screened to the Pediatric Randomized of Early versus Deferred Initiation in Cambodia and Thailand study. The overall sensitivity and specificity were 34% and 98%, respectively. Using the current CD4 count criteria would globally result in 66% missed opportunity to initiate treatment in a timely fashion. Raising CD4 count thresholds should be considered to increase its sensitivity and reduce missed opportunity. specialized HIV CD4 antiretroviral treatment ART initiation WHO children Asia 052 050 29 10 966-968 2010 0891-3668 https://www.documentation.ird.fr/hor/fdi:010092295 10.1097/INF.0b013e3181e0554c 0891-3668 [F B010092295] https://www.documentation.ird.fr/hor/fdi:010092295 https://www.documentation.ird.fr/intranet/publi/2024-12/010092295.pdf Accès réservé (Intranet de l'IRD) IRD - Base Horizon / Pleins textes 2010-11-05 2024-12-10 fdi:010092295 fre